June 6, 2013 / 6:16 AM / 4 years ago

BRIEF-Alliance Pharma buys Syntometrinetm rights from Novartis

LONDON, June 6 (Reuters) - Alliance Pharma PLC : * Acquired all existing rights to SyntometrineTM from Novartis for

$11.5 million

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below